1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: E-1694, CAN-NCIC-ME9, MDA-DM-E1694, MSKCC-96008, SWOG-9512, CAN-NCIC-E1694, MSKCC-E1694, SWOG-E1694, E1694, ME9
|
|
2.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 to 80 Sponsor: Other Protocol IDs: CDR0000067645, EORTC-18961, BMS-CA152-003, NCT00005052
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: MSKCC-94029, NCI-V94-0467
|
|
4.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: over 18 Sponsor: NCI Protocol IDs: MSKCC-95029A3, NCI-H95-0683
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: MSKCC-93087A1, NCI-V94-0348
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: any age Sponsor: Protocol IDs: MSKCC-94009A1, NCI-V94-0458
|
|
7.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: MSKCC-94041, NCI-H94-0471
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: E-2696, E2696
|
|
9.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UKMC-95GI24CB, NCI-H97-1184
|
|
10.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-97122, NCI-G98-1378
|
|
11.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-98002, NCI-G98-1440
|
|
12.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-98012, NCI-T97-0110, NCT00003362, T97-0110
|
|
13.
|
Phase: Phase II Type: Treatment Status: Completed Age: Over 16 Sponsor: NCI Protocol IDs: MSKCC-99012, NCI-H99-0036, NCT00004052
|
|
14.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-98065, NCI-H99-0047, NCT00004249
|
|
15.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-99056, NCI-G00-1697, NCT00004929
|
|
16.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-00064, NCI-G01-1940, NCT00016120
|
|
17.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-01140, NCI-G02-2064, NCT00036933
|
|
18.
|
Phase: Phase II Type: Treatment Status: Closed Age: any age Sponsor: Protocol IDs: MSKCC-91071, NCI-V91-0179
|
|
19.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MSKCC-92100, NCI-V92-0144
|
|
20.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MSKCC-92168, NCI-V93-0228
|
|
21.
|
Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: MSKCC-92169, NCI-V93-0229
|
|
22.
|
Phase: Phase I Type: Treatment Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: MSKCC-95052, NCI-H95-0769
|
|
23.
|
Phase: Phase I Type: Treatment Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: NCI-97-C-0018, CRB-9411, NCI-NMOB-9608, NCI-T95-0048N, T95-0048
|
|
24.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: RPCI-DS-94-23, FCCC-98025, NCI-V96-1035
|
|
25.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-96055A1, NCI-V97-1119
|